Artificial Organ & Bionics Market by Product (Artificial Bionics, Artificial Organ), Technology (Electronic, Mechanical) - Global Forecast 2024-2030
The Artificial Organ & Bionics Market size was estimated at USD 23.34 billion in 2023 and expected to reach USD 25.45 billion in 2024, at a CAGR 9.10% to reach USD 42.97 billion by 2030.
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Artificial Organ & Bionics Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Artificial Organ & Bionics Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Artificial Organ & Bionics Market, highlighting leading vendors and their innovative profiles. These include Alt-Bionics, LLC, Axiles Bionics, Baxter International Inc., Berlin Heart GmbH, Beta Bionics, Inc., Bionic India, Boston Scientific Corporation, Carmat SA, COVVI Ltd., Ekso Bionics Holdings, Inc., German Bionic Systems GmbH, iWALKFree, Inc., Jarvik Heart, Inc., Medtronic Plc, Nipro Corporation, Open Bionics Ltd., Pixium Vision SA, ReWalk Robotics Ltd., Sonova AG, SynCardia Systems, LLC, Vivani Medical, Inc., Zimmer Biomet Holdings, Inc., and Össur hf..
Market Segmentation & Coverage
This research report categorizes the Artificial Organ & Bionics Market to forecast the revenues and analyze trends in each of the following sub-markets:
Product
Artificial Bionics
Bionic Limbs
Heart
Electronic
Americas
Argentina
California
Australia
Denmark
The report offers valuable insights on the following aspects:
- Market Penetration: It presents comprehensive information on the market provided by key players.
- Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
- Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
- Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
- Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
- What is the market size and forecast of the Artificial Organ & Bionics Market?
- Which products, segments, applications, and areas should one consider investing in over the forecast period in the Artificial Organ & Bionics Market?
- What are the technology trends and regulatory frameworks in the Artificial Organ & Bionics Market?
- What is the market share of the leading vendors in the Artificial Organ & Bionics Market?
- Which modes and strategic moves are suitable for entering the Artificial Organ & Bionics Market?
Note: PDF & Excel + Online Access - 1 Year
- 1. Preface
- 1.1. Objectives of the Study
- 1.2. Market Segmentation & Coverage
- 1.3. Years Considered for the Study
- 1.4. Currency & Pricing
- 1.5. Language
- 1.6. Limitations
- 1.7. Assumptions
- 1.8. Stakeholders
- 2. Research Methodology
- 2.1. Define: Research Objective
- 2.2. Determine: Research Design
- 2.3. Prepare: Research Instrument
- 2.4. Collect: Data Source
- 2.5. Analyze: Data Interpretation
- 2.6. Formulate: Data Verification
- 2.7. Publish: Research Report
- 2.8. Repeat: Report Update
- 3. Executive Summary
- 4. Market Overview
- 4.1. Introduction
- 4.2. Artificial Organ & Bionics Market, by Region
- 5. Market Insights
- 5.1. Market Dynamics
- 5.1.1. Drivers
- 5.1.1.1. Rising incidences of organ failure due to chronic diseases
- 5.1.1.2. Increasing cases of road accidents leading to amputations
- 5.1.1.3. Modernization of healthcare infrastructure and rise in healthcare spending
- 5.1.2. Restraints
- 5.1.2.1. High costs associated with artificial implantation procedures
- 5.1.3. Opportunities
- 5.1.3.1. Advancement in the implantation of artificial organ procedures
- 5.1.3.2. Development of new and improved artificial organs
- 5.1.4. Challenges
- 5.1.4.1. Availability of stringent regulatory frameworks
- 5.2. Market Segmentation Analysis
- 5.3. Market Trend Analysis
- 5.4. Cumulative Impact of High Inflation
- 5.5. Porter’s Five Forces Analysis
- 5.5.1. Threat of New Entrants
- 5.5.2. Threat of Substitutes
- 5.5.3. Bargaining Power of Customers
- 5.5.4. Bargaining Power of Suppliers
- 5.5.5. Industry Rivalry
- 5.6. Value Chain & Critical Path Analysis
- 5.7. Regulatory Framework
- 6. Artificial Organ & Bionics Market, by Product
- 6.1. Introduction
- 6.2. Artificial Bionics
- 6.3.1. Bionic Limbs
- 6.3.2. Brain Bionics
- 6.3.3. Cochlear Implants
- 6.3.4. Exoskeleton
- 6.3.5. Vision Bionics
- 6.3. Artificial Organ
- 6.4.1. Heart
- 6.4.2. Kidney
- 6.4.3. Liver
- 6.4.4. Lungs
- 6.4.5. Pancreas
- 7. Artificial Organ & Bionics Market, by Technology
- 7.1. Introduction
- 7.2. Electronic
- 7.3. Mechanical
- 8. Americas Artificial Organ & Bionics Market
- 8.1. Introduction
- 8.2. Argentina
- 8.3. Brazil
- 8.4. Canada
- 8.5. Mexico
- 8.6. United States
- 9. Asia-Pacific Artificial Organ & Bionics Market
- 9.1. Introduction
- 9.2. Australia
- 9.3. China
- 9.4. India
- 9.5. Indonesia
- 9.6. Japan
- 9.7. Malaysia
- 9.8. Philippines
- 9.9. Singapore
- 9.10. South Korea
- 9.11. Taiwan
- 9.12. Thailand
- 9.13. Vietnam
- 10. Europe, Middle East & Africa Artificial Organ & Bionics Market
- 10.1. Introduction
- 10.2. Denmark
- 10.3. Egypt
- 10.4. Finland
- 10.5. France
- 10.6. Germany
- 10.7. Israel
- 10.8. Italy
- 10.9. Netherlands
- 10.10. Nigeria
- 10.11. Norway
- 10.12. Poland
- 10.13. Qatar
- 10.14. Russia
- 10.15. Saudi Arabia
- 10.16. South Africa
- 10.17. Spain
- 10.18. Sweden
- 10.19. Switzerland
- 10.20. Turkey
- 10.21. United Arab Emirates
- 10.22. United Kingdom
- 11. Competitive Landscape
- 11.1. FPNV Positioning Matrix
- 11.2. Market Share Analysis, By Key Player
- 11.3. Competitive Scenario Analysis, By Key Player
- 12. Competitive Portfolio
- 12.1. Key Company Profiles
- 12.1.1. Alt-Bionics, LLC
- 12.1.2. Axiles Bionics
- 12.1.3. Baxter International Inc.
- 12.1.4. Berlin Heart GmbH
- 12.1.5. Beta Bionics, Inc.
- 12.1.6. Bionic India
- 12.1.7. Boston Scientific Corporation
- 12.1.8. Carmat SA
- 12.1.9. COVVI Ltd.
- 12.1.10. Ekso Bionics Holdings, Inc.
- 12.1.11. German Bionic Systems GmbH
- 12.1.12. iWALKFree, Inc.
- 12.1.13. Jarvik Heart, Inc.
- 12.1.14. Medtronic Plc
- 12.1.15. Nipro Corporation
- 12.1.16. Open Bionics Ltd.
- 12.1.17. Pixium Vision SA
- 12.1.18. ReWalk Robotics Ltd.
- 12.1.19. Sonova AG
- 12.1.20. SynCardia Systems, LLC
- 12.1.21. Vivani Medical, Inc.
- 12.1.22. Zimmer Biomet Holdings, Inc.
- 12.1.23. Össur hf.
- 12.2. Key Product Portfolio
- 13. Appendix
- 13.1. Discussion Guide
- 13.2. License & Pricing
- FIGURE 1. ARTIFICIAL ORGAN & BIONICS MARKET RESEARCH PROCESS
- FIGURE 2. ARTIFICIAL ORGAN & BIONICS MARKET SIZE, 2023 VS 2030
- FIGURE 3. ARTIFICIAL ORGAN & BIONICS MARKET SIZE, 2018-2030 (USD MILLION)
- FIGURE 4. ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
- FIGURE 5. ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 6. ARTIFICIAL ORGAN & BIONICS MARKET DYNAMICS
- FIGURE 7. ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
- FIGURE 8. ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 9. ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
- FIGURE 10. ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 11. AMERICAS ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 12. AMERICAS ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 13. UNITED STATES ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
- FIGURE 14. UNITED STATES ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 15. ASIA-PACIFIC ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 16. ASIA-PACIFIC ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 17. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 18. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL ORGAN & BIONICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 19. ARTIFICIAL ORGAN & BIONICS MARKET, FPNV POSITIONING MATRIX, 2023
- FIGURE 20. ARTIFICIAL ORGAN & BIONICS MARKET SHARE, BY KEY PLAYER, 2023
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook